# BioStem Technologies, Inc. (BSEM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BSEM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 14.03M | $ -17.79M | $ -6.42M | $ 1.22M | $ 27.61M |
| 2025 | $ 48.62M | $ -6.74M | $ 6.75M | $ 3.33M | $ 39.14M |
| 2024 | $ 317.24M | $ 33.51M | $ 25.27M | $ 4.39M | $ 40.88M |
| 2023 | $ 18.04M | $ -7.50M | $ -3.88M | $ 4.72M | $ -1.34M |
| 2022 | $ 7.68M | $ -8.02M | $ -185.4K | $ 5.09M | $ -4.08M |
| 2021 | $ 5.24M | $ -2.19M | $ -704.2K | $ 4.89M | $ -5.96M |
| 2020 | $ 3.21M | $ -3.06M | $ -740.9K | $ 5.63M | $ -5.80M |
| 2019 | $ 3.40M | $ -8.24M | $ -1.26M | $ 5.11M | $ -4.09M |
| 2018 | $ 1.34M | $ -10.03M | $ -5.10M | $ 5.20M | $ -1.61M |
| 2017 | $ 421.9K | $ -5.18M | $ -2.42M | $ 1.00M | $ 817.6K |
| 2016 | $ 904.8K | $ -4.98M | $ -3.35M | $ 900.0K | $ 3.41M |
| 2015 | $ 212.8K | $ -3.34M | $ -2.95M | $ 500.0K | $ 1.64M |
| 2014 | $ 44.1K | $ -402.7K | $ -119.6K | $ 199.7K | $ -75.9K |
| 2013 | $ 21.8K | $ -628.3K | $ -524.9K | $ 39.5K | $ 102.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.77 |
| Current Ratio | 0.98 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / FCF | 1.34 |

## Other views

- [Metrics](https://sponda.capital/en/BSEM.md)
- [Charts](https://sponda.capital/en/BSEM/charts.md)
- [Compare](https://sponda.capital/en/BSEM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.